BUTENAFINE HYDROCHLORIDE and DRUG EFFECTIVE FOR UNAPPROVED INDICATION

Overview

DRUG EFFECTIVE FOR UNAPPROVED INDICATION is the #11 most commonly reported adverse reaction for BUTENAFINE HYDROCHLORIDE, manufactured by Bayer Healthcare LLC.. There are 17 FDA adverse event reports linking BUTENAFINE HYDROCHLORIDE to DRUG EFFECTIVE FOR UNAPPROVED INDICATION. This represents approximately 1.9% of all 901 adverse event reports for this drug.

Patients taking BUTENAFINE HYDROCHLORIDE who experience drug effective for unapproved indication should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG EFFECTIVE FOR UNAPPROVED INDICATION is a less commonly reported adverse event for BUTENAFINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of BUTENAFINE HYDROCHLORIDE

In addition to drug effective for unapproved indication, the following adverse reactions have been reported for BUTENAFINE HYDROCHLORIDE:

• DRUG INEFFECTIVE — 180 reports
• OFF LABEL USE — 59 reports
• PRODUCT USE ISSUE — 43 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 34 reports
• PRURITUS — 31 reports
• CONDITION AGGRAVATED — 29 reports
• RASH — 21 reports
• DRUG EFFECT DECREASED — 19 reports
• DRUG INEFFECTIVE FOR UNAPPROVED INDICATION — 19 reports
• ERYTHEMA — 19 reports

Other Drugs Associated with DRUG EFFECTIVE FOR UNAPPROVED INDICATION

The following drugs have also been linked to drug effective for unapproved indication in FDA adverse event reports:

Does BUTENAFINE HYDROCHLORIDE cause DRUG EFFECTIVE FOR UNAPPROVED INDICATION?

DRUG EFFECTIVE FOR UNAPPROVED INDICATION has been reported as an adverse event in 17 FDA reports for BUTENAFINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG EFFECTIVE FOR UNAPPROVED INDICATION with BUTENAFINE HYDROCHLORIDE?

DRUG EFFECTIVE FOR UNAPPROVED INDICATION accounts for approximately 1.9% of all adverse event reports for BUTENAFINE HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience DRUG EFFECTIVE FOR UNAPPROVED INDICATION while taking BUTENAFINE HYDROCHLORIDE?

If you experience drug effective for unapproved indication while taking BUTENAFINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages